Back
Predictive Oncology 10K Form
Buy
54
POAI
Predictive Oncology
Last Price:
$1.18
Seasonality Move:
-17.66%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-13 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-06-11 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-06-08 | 10Q | POAI/Predictive Oncology Quarterly |
| 2020-04-01 | 10K | POAI/Predictive Oncology Annual |
| 2019-11-15 | 10Q | POAI/Predictive Oncology Quarterly |
| 2019-08-19 | 10Q | POAI/Predictive Oncology Quarterly |
Receive POAI News And Ratings
See the #1 stock for the next 7 days that we like better than POAI
POAI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.8M |
|---|---|
| Cash Flow: | $-2.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.29 |
| Price / Book: | 4.07 |
Profitability
| EPS (TTM): | -3.05000 |
|---|---|
| Net Income (TTM): | $-14M |
| Gross Margin: | $1.1M |
| Return on Equity: | -232.54% |
| Return on Assets: | -114% |
Predictive Oncology Earnings Forecast
Key Predictive Oncology Financial Ratios
-
The Gross Profit Margin over the past 16 years for POAI is 64.34%.
-
The Selling, General & Administrative Expenses for POAI have been equal to 614.54% of Gross Profit Margin.
-
The Research & Development expenses have been 187.66% of Revenue.
-
The Net Earning history of POAI is -785.58% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 13 years.
Predictive Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | POAI |
| CUSIP: | 74039M |
| Website: | predictive-oncology.com |
Debt
| Debt-to-Equity Ratio: | 0.1 |
|---|---|
| Current Ratio: | 1.2 |
| Quick Ratio: | 0.93 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
POAI Technical Analysis vs Fundamental Analysis
Buy
54
Predictive Oncology (POAI)
is a Buy
Is Predictive Oncology a Buy or a Sell?
-
Predictive Oncology stock is rated a BuyThe current Predictive Oncology [POAI] share price is $1.20. The Score for POAI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.